Radiation Therapy With Monoclonal Antibodies
Warnings about serious side effects of ibritumomab (Zevalin) have been issued by the U.S. Food and Drug Administration (FDA). Some of these side effects have been fatal. These side effects include trouble breathing; closing of the throat; swollen lips, tongue, or face; heart problems; and severe skin reactions. If you develop any of these symptoms, contact your doctor immediately.
Ibritumomab and tositumomab may cause birth defects. Do not receive this therapy if you are pregnant or if you wish to become pregnant or father a child while you are taking these medicines.
Serious side effects of ibritumomab and tositumomab may include:
- Blood disorders and Reference leukemia Opens New Window.
- Reduced production of Reference bone marrow Opens New Window.
- Reference Hypothyroidism Opens New Window.
Less serious side effects may include:
- Abdominal pain.
- Muscle or joint pain.
- Nausea or vomiting.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
|By:||Reference Healthwise Staff||Last Revised: March 29, 2012|
|Medical Review:||Reference Anne C. Poinier, MD - Internal Medicine
Reference Douglas A. Stewart, MD - Medical Oncology